Post-CA Neuroprotection With Magnesium

PHASE1RecruitingINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

March 25, 2025

Primary Completion Date

March 30, 2026

Study Completion Date

June 30, 2026

Conditions
Cardiac ArrestReturn of Spontaneous Circulation
Interventions
DRUG

Magnesium Sulfate

4 g of magnesium sulfate intravenously within 2 hours of Return of Spontaneous Circulation (ROSC), followed by a continuous drip (16 g) over 24 hours

DRUG

Saline

Control subjects will receive an equivalent volume of normal saline intravenously.

Trial Locations (1)

10016

RECRUITING

NYU Langone Health, New York

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

NYU Langone Health

OTHER